NCT00225108View on ClinicalTrials.gov

The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

September 30, 2006

Conditions
Deep Vein Thrombosis
Interventions
DRUG

Tinzaparin

Trial Locations (1)

K1H 8L6

Ottawa Hospital, Ottawa

Sponsors

Collaborators (1)

LEO Pharma
All Listed Sponsors
collaborator

LEO Pharma

INDUSTRY

lead

Ottawa Hospital Research Institute

OTHER